ArticleFrontiers in oncology2025

Case Report: Pathologic complete response in a patient with simultaneous diagnoses of resectable NSCLC and myeloid neoplasm with PDGFRA rearrangement treated with concurrent neoadjuvant chemoimmunotherapy and imatinib: translating clinical trial data to real-world practice.

Chad B Sussman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.